Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-24 @ 9:28 PM
NCT ID:
NCT06888232
Eligibility Criteria:
Inclusion Criteria:
* Children of both genders
* Aged 2-5 years
* With transfusion-dependent thalassemia (TDT)
* Whose parents/guardians showed willingness to adhere to follow-up visits
Exclusion Criteria:
* Children with uncontrolled infections
* Significant hepatic or renal dysfunction
* Malignancy
* Known contraindications to thalidomide
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
5 Years
Study:
NCT06888232
Study Brief:
Protocol Section:
NCT06888232